Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder
- PMID: 38847247
- DOI: 10.2174/0113816128312442240519184440
Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder
Abstract
Bipolar disorder is a neuropsychiatric disease characterized by an abundance of undesired ideas and thoughts associated with recurrent episodes of mania or hypomania and depression. Alterations in the circuits, including the prefrontal cortex, striatum, and limbic system, regulate mood and cause variation in several crucial neurotransmitters, including serotonin, dopamine, GABA, and glutamate. Imbalances in dopamine levels have been implicated in the manic phase, while variance in serotonin is linked to depressive episodes. The precise pathophysiology of bipolar disorder is still unknown. Though different treatments are available, like lithium, risperidone, valproic acid, etc., which are widely used, they come with certain limitations, including narrow therapeutic index, hypothyroidism, weight gain, extrapyramidal symptoms, etc. The interest in herbal- based treatments for bipolar disorder arises from the desire for alternative, potentially more natural, and holistic approaches with fewer side effects. The current review focuses on the potential effects of herbal drugs and their derivatives to alleviate the symptoms of bipolar disorder.
Keywords: Bipolar disorder; anxiety.; depression; herbal drugs; neurotransmitters; pharmacological mechanisms.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
Quetiapine: a review of its use in the management of bipolar depression.CNS Drugs. 2012 May 1;26(5):435-60. doi: 10.2165/11203840-000000000-00000. CNS Drugs. 2012. PMID: 22519923 Review.
-
Bipolar II disorder : epidemiology, diagnosis and management.CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003. CNS Drugs. 2007. PMID: 17696573 Review.
-
Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.Curr Drug Metab. 2018;19(8):663-673. doi: 10.2174/1389200219666171227203737. Curr Drug Metab. 2018. PMID: 29283064 Review.
-
Lithium for acute mania.Cochrane Database Syst Rev. 2019 Jun 1;6(6):CD004048. doi: 10.1002/14651858.CD004048.pub4. Cochrane Database Syst Rev. 2019. PMID: 31152444 Free PMC article.
References
-
- Schiweck C.; Henriquez A.G.; Aichholzer M.; Thanarajah E.S.; Cáceres V.S.; Matura S.; Grimm O.; Haavik J.; Schneider K.S.; Quiroga R.J.A.; Faraone S.V.; Reif A.; Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021,124,100-123 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical